The FDA conducted inspections at nine different biologics companies in Arkansas throughout 2025, according to the U.S. Food and Drug Administration (FDA).
These inspections represented the second-largest number of visits by the FDA to any single company type in Arkansas, accounting for 10.1% of all inspections conducted in the state that year.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Bioresearch Monitoring | 3 | 1 | — |
| Blood and Blood Products | 8 | — | — |
| Compliance: Devices | 2 | — | — |
| Drug Quality Assurance | 1 | 1 | 2 |
| Food Composition, Standards, Labeling and Econ | 6 | 4 | 2 |
| Foodborne Biological Hazards | 55 | 6 | 3 |
| Human Cellular, Tissue, and Gene Therapies | 1 | — | — |
| Monitoring of Marketed Animal Drugs, Feed, and Devices | 2 | — | — |
| Technical Assistance: Food and Cosmetics | 10 | — | — |
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
